ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    facet.materialart.
    Unknown
    Innovative approaches to plasminogen activator therapy (1989)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 1989-01-06
    Description: Plasminogen activator therapy for acute myocardial infarction has become standard medical practice. Bleeding complications, however, limit the utility of the currently available agents. This article reviews how the tools of molecular biology and protein engineering are being used to develop safer and more effective plasminogen activators.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Haber, E -- Quertermous, T -- Matsueda, G R -- Runge, M S -- HL-19259/HL/NHLBI NIH HHS/ -- HL-28015/HL/NHLBI NIH HHS/ -- New York, N.Y. -- Science. 1989 Jan 6;243(4887):51-6.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Cardiac Unit, Massachusetts General Hospital, Boston 02114.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/2492113" target="_blank"〉PubMed〈/a〉
    Keywords: Humans ; Myocardial Infarction/*drug therapy ; Plasminogen Activators/*therapeutic use ; Protein Conformation ; Recombinant Proteins/therapeutic use ; Streptokinase/therapeutic use ; Tissue Plasminogen Activator/therapeutic use ; Urokinase-Type Plasminogen Activator/therapeutic use
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
  • 2
    facet.materialart.
    Unknown
    Break-induced replication repair of damaged forks induces genomic duplications in human cells (2013)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 2013-12-07
    Description: In budding yeast, one-ended DNA double-strand breaks (DSBs) and damaged replication forks are repaired by break-induced replication (BIR), a homologous recombination pathway that requires the Pol32 subunit of DNA polymerase delta. DNA replication stress is prevalent in cancer, but BIR has not been characterized in mammals. In a cyclin E overexpression model of DNA replication stress, POLD3, the human ortholog of POL32, was required for cell cycle progression and processive DNA synthesis. Segmental genomic duplications induced by cyclin E overexpression were also dependent on POLD3, as were BIR-mediated recombination events captured with a specialized DSB repair assay. We propose that BIR repairs damaged replication forks in mammals, accounting for the high frequency of genomic duplications in human cancers.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047655/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047655/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Costantino, Lorenzo -- Sotiriou, Sotirios K -- Rantala, Juha K -- Magin, Simon -- Mladenov, Emil -- Helleday, Thomas -- Haber, James E -- Iliakis, George -- Kallioniemi, Olli P -- Halazonetis, Thanos D -- R01 GM076020/GM/NIGMS NIH HHS/ -- R37 GM020056/GM/NIGMS NIH HHS/ -- New York, N.Y. -- Science. 2014 Jan 3;343(6166):88-91. doi: 10.1126/science.1243211. Epub 2013 Dec 5.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Molecular Biology, University of Geneva, 1205 Geneva, Switzerland.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/24310611" target="_blank"〉PubMed〈/a〉
    Keywords: Cell Cycle ; Cyclin E/biosynthesis/genetics ; *DNA Breaks, Double-Stranded ; DNA Polymerase III/genetics/*physiology ; DNA Repair/*genetics ; DNA Replication/*genetics ; *Gene Duplication ; Humans ; Neoplasms/*genetics
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
  • 3
    facet.materialart.
    Unknown
    Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen (1983)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 1983-12-09
    Description: A synthetic heptapeptide from the amino terminus of the beta chain in human fibrin was used as an antigen to produce monoclonal antibodies that bind to fibrin even in the presence of human fibrinogen at the concentration found in plasma. As expected, the antifibrin activity was inhibited by the peptide antigen but not by a control heptapeptide. In a chicken ex vivo circulatory model for fibrin detection, intravenously administered monoclonal antibodies bound to human fibrin-coated disks placed in an extracorporeal chamber. These findings may lead to better methods for identifying deep vein and coronary artery thrombi.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Hui, K Y -- Haber, E -- Matsueda, G R -- HL28015/HL/NHLBI NIH HHS/ -- New York, N.Y. -- Science. 1983 Dec 9;222(4628):1129-32.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6648524" target="_blank"〉PubMed〈/a〉
    Keywords: Antibodies, Monoclonal/*immunology ; Antibody Specificity ; Fibrin/*immunology ; Fibrinogen/*immunology ; Humans ; Peptide Fragments/chemical synthesis/immunology ; Polymers
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
  • 4
    facet.materialart.
    Unknown
    Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines (1978)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 1978-03-31
    Description: Peripheral lymphocytes from human volunteers boosted with tetanus toxoid were cultured after in vitro infection with Epstein-Barr virus. Forty-four continuous lymphoblastoid lines were established which continued to secrete human gamma globulin; seven of these secreted antibody to tetanus toxoid. Subcultures derived from limiting dilution experiments continued to secrete the antibody. Some of these antibody-secreting cells have been in continuous culture for more than 6 months.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Zurawski, V R Jr -- Haber, E -- Black, P H -- New York, N.Y. -- Science. 1978 Mar 31;199(4336):1439-41.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/204013" target="_blank"〉PubMed〈/a〉
    Keywords: Antibody Formation ; Antibody Specificity ; Cell Line ; Clone Cells/immunology ; Herpesvirus 4, Human ; Histological Techniques ; Humans ; Lymphocytes/*immunology ; *Tetanus Antitoxin ; *Tetanus Toxoid
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
  • 5
    facet.materialart.
    Unknown
    Antibody-directed urokinase: a specific fibrinolytic agent (1985)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 1985-08-23
    Description: A specific fibrinolytic agent was synthesized by covalently coupling urokinase to a monoclonal antibody that was fibrin-specific and did not cross-react with fibrinogen. The antibody was raised against a synthetic peptide representing the seven amino-terminal residues of the beta chain of human fibrin. The urokinase-antifibrin conjugate retained the original binding specificity of the antibody and showed 100-fold increased fibrinolysis in vitro when compared to unmodified urokinase. The presence of human fibrinogen at plasma concentration did not influence these properties.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Bode, C -- Matsueda, G R -- Hui, K Y -- Haber, E -- New York, N.Y. -- Science. 1985 Aug 23;229(4715):765-7.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/4023710" target="_blank"〉PubMed〈/a〉
    Keywords: Antibodies, Monoclonal/*therapeutic use ; Cross-Linking Reagents ; Fibrin/immunology ; *Fibrinolysis ; Humans ; In Vitro Techniques ; Kinetics ; Structure-Activity Relationship ; Urokinase-Type Plasminogen Activator/*administration & dosage
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...